HPTN 083: Injectable PrEP can make breakthrough infections hard to detect
HIV capsid inhibitor offers new option for people with highly resistant HIV
Resistance testing does not improve viral suppression after first-line failure in South Africa and Uganda
African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir
Alendronate can prevent bone loss in people starting HIV treatment
Reformulated islatravir implant should provide PrEP for over a year
Near point-of-care viral load tests slash waiting times in seven African countries
Similar rate of severe clinical outcomes with two drug vs three drug HIV treatment combinations
Antibiotics to prevent STIs – for or against?
